These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9520622)

  • 21. Key developments in cardiovascular medicine.
    Appleby MA; Hall A
    Practitioner; 2002 Jun; 246(1635):375-7, 380-2. PubMed ID: 12073696
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lipid metabolism--effect of cardiac agents and ACE inhibitors. Effects of anti-arrhythmia agents, ACE inhibitors, positive inotropic substance and anti-angina agents].
    Möhrle W; Sühler K; Richter WO; Schwandt P
    Fortschr Med; 1993 Feb; 111(5):61-4. PubMed ID: 8449471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 25. Alleviating angina. New guidelines update advice on treating chest pain.
    Ornato JP
    Health News; 2003 Mar; 9(3):3. PubMed ID: 12703433
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of ramipril on postrevascularization prevalence of angina and quality of life.
    Kjøller-Hansen L; Steffensen R; Grande P
    Int J Cardiol; 2004 Jun; 95(2-3):159-65. PubMed ID: 15193814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibition by Brazilian plants.
    Braga FC; Serra CP; Viana NS; Oliveira AB; Côrtes SF; Lombardi JA
    Fitoterapia; 2007 Jul; 78(5):353-8. PubMed ID: 17513067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys].
    MMW Fortschr Med; 2002 Oct; 144(44):53. PubMed ID: 12494601
    [No Abstract]   [Full Text] [Related]  

  • 33. [[Angiotensin I converting enzyme: what results from new findings] ].
    Pospísilová Y; Brychtová Y
    Vnitr Lek; 2000 Mar; 46(3):166-9. PubMed ID: 11048520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure.
    Carson PE
    Am Heart J; 2000 Sep; 140(3):361-6. PubMed ID: 10966531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiarrhythmic properties of angiotensin converting enzyme inhibitors].
    Dzielska-Olczak M
    Wiad Lek; 1998; 51(9-10):424-9. PubMed ID: 9921106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of angiotensin-converting enzyme inhibitors in the treatment of heart failure in the 21st century].
    Gibelin P
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):41-5. PubMed ID: 11933555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
    Ahmed A; Allman RM; DeLong JF; Bodner EV; Howard G
    South Med J; 2002 Jul; 95(7):703-10. PubMed ID: 12144075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Information from your family doctor. What should I know about ACE inhibitors?
    Am Fam Physician; 2002 Aug; 66(3):473. PubMed ID: 12182525
    [No Abstract]   [Full Text] [Related]  

  • 40. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.